Hepatitis B maternal-fetal transmission in Southern Europe. 1998

G Papaevangelou, and G Farmaki, and H Kada
University of Athens, Nursing School and Regional General and Maternity Hospital 'Helena Venizelou', Athens, Greece. gpapaeva@atlas.uoa.gr

Screening of pregnant women for hepatitis B surface antigen especially in countries with a high carrier rate as in Southern Europe is absolutely necessary for the control and elimination of the disease. In most Southern European countries screening of pregnant women is highly recommended. In Greece the carrier rate in pregnant women varies between 2.8 and 3.0%. However, only 63.1% of mothers at delivery had been screened before admission to the maternity hospital. To avoid legal problems arising from obligatory screening, educational campaigns, lectures, pamphlets and further measures to increase screening of pregnant women and administering hepatitis B immunoglobulin and vaccine should be taken.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018445 Infectious Disease Transmission, Vertical The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding. Fetomaternal Infection Transmission,Infection Transmission, Fetomaternal,Infection Transmission, Maternal-Fetal,Infection Transmission, Vertical,Maternal-Fetal Infection Transmission,Mother-to-Child Transmission,Pathogen Transmission, Vertical,Vertical Infection Transmission,Vertical Infectious Disease Transmission,Vertical Transmission of Infectious Disease,Infection Transmission, Maternal Fetal,Maternal Fetal Infection Transmission,Mother to Child Transmission,Mother-to-Child Transmissions,Transmission, Fetomaternal Infection,Transmission, Maternal-Fetal Infection,Transmission, Mother-to-Child,Transmission, Vertical Infection,Transmission, Vertical Pathogen,Transmissions, Mother-to-Child,Vertical Pathogen Transmission

Related Publications

G Papaevangelou, and G Farmaki, and H Kada
December 1975, The New England journal of medicine,
G Papaevangelou, and G Farmaki, and H Kada
November 1978, The Journal of infectious diseases,
G Papaevangelou, and G Farmaki, and H Kada
December 1988, Nihon rinsho. Japanese journal of clinical medicine,
G Papaevangelou, and G Farmaki, and H Kada
March 1977, The New England journal of medicine,
G Papaevangelou, and G Farmaki, and H Kada
September 1992, Zhonghua fu chan ke za zhi,
G Papaevangelou, and G Farmaki, and H Kada
October 2008, World journal of gastroenterology,
G Papaevangelou, and G Farmaki, and H Kada
September 1978, Lancet (London, England),
G Papaevangelou, and G Farmaki, and H Kada
July 1976, The New England journal of medicine,
G Papaevangelou, and G Farmaki, and H Kada
June 2014, Journal of clinical and translational hepatology,
G Papaevangelou, and G Farmaki, and H Kada
March 1985, International journal of epidemiology,
Copied contents to your clipboard!